-
Ketamine One Teams Up With Cognetivity Neurosciences To Study PTSD, Depression
Thursday, December 2, 2021 - 1:33pm | 357Ketamine One, a Canada-based health and wellness company focused on treatments for mental health, is teaming up with Cognetivity Neurosciences (OTCMKTS: CGNSF) for a collaborative study on treatments for PTSD and depression, the companies announced in a press release on Thursday. Ketamine One...